InVivo Therapeutics Holdings Free Cash Flow 2010-2023 | NVIVQ
InVivo Therapeutics Holdings Annual Free Cash Flow | |
---|---|
2022 | -10.64 |
2021 | -8.93 |
2020 | -9.58 |
2019 | -10.33 |
2018 | -12.38 |
2017 | -19.75 |
2016 | -16.85 |
2015 | -16.33 |
2014 | -15.29 |
2013 | -15.66 |
2012 | -12.35 |
2011 | -7.71 |
2010 | -2.80 |
2009 | -2.07 |
2009 | -0.02 |
InVivo Therapeutics Holdings Quarterly Free Cash Flow | |
---|---|
2023-09-30 | -7.87 |
2023-06-30 | -5.63 |
2023-03-31 | -3.20 |
2022-12-31 | -10.64 |
2022-09-30 | -8.43 |
2022-06-30 | -6.00 |
2022-03-31 | -3.86 |
2021-12-31 | -8.93 |
2021-09-30 | -6.86 |
2021-06-30 | -4.94 |
2021-03-31 | -3.24 |
2020-12-31 | -9.58 |
2020-09-30 | -7.64 |
2020-06-30 | -5.71 |
2020-03-31 | -3.72 |
2019-12-31 | -10.33 |
2019-09-30 | -8.43 |
2019-06-30 | -6.66 |
2019-03-31 | -3.36 |
2018-12-31 | -12.38 |
2018-09-30 | -9.39 |
2018-06-30 | -6.84 |
2018-03-31 | -3.67 |
2017-12-31 | -19.75 |
2017-09-30 | -15.64 |
2017-06-30 | -11.03 |
2017-03-31 | -6.16 |
2016-12-31 | -16.85 |
2016-09-30 | -12.62 |
2016-06-30 | -8.26 |
2016-03-31 | -4.21 |
2015-12-31 | -16.33 |
2015-09-30 | -10.98 |
2015-06-30 | -7.15 |
2015-03-31 | -2.91 |
2014-12-31 | -15.29 |
2014-09-30 | -11.08 |
2014-06-30 | -7.85 |
2014-03-31 | -4.23 |
2013-12-31 | -15.66 |
2013-09-30 | -11.37 |
2013-06-30 | -7.23 |
2013-03-31 | -3.08 |
2012-12-31 | -12.35 |
2012-09-30 | -8.03 |
2012-06-30 | -5.33 |
2012-03-31 | -3.20 |
2011-12-31 | -7.71 |
2011-09-30 | -5.39 |
2011-06-30 | -3.99 |
2011-03-31 | -2.10 |
2010-12-31 | -2.80 |
2010-09-30 | -1.77 |
2010-06-30 | -1.14 |
2010-03-31 | -0.44 |
2009-12-31 | -0.08 |
2009-09-30 | -0.08 |
2009-06-30 | -0.07 |
2009-03-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.001B | $0.000B |
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $203.272B | 26.25 |
Stryker (SYK) | United States | $140.156B | 32.75 |
Boston Scientific (BSX) | United States | $123.450B | 37.59 |
Medtronic (MDT) | Ireland | $115.424B | 17.18 |
EssilorLuxottica (ESLOY) | France | $105.988B | 0.00 |
Haleon (HLN) | United Kingdom | $47.352B | 34.60 |
Lonza Group Ag (LZAGY) | Switzerland | $46.218B | 0.00 |
ResMed (RMD) | United States | $36.837B | 32.43 |
Koninklijke Philips (PHG) | Netherlands | $28.913B | 21.97 |
Terumo (TRUMY) | Japan | $27.831B | 39.31 |
Zimmer Biomet Holdings (ZBH) | United States | $21.412B | 13.48 |
Baxter (BAX) | United States | $20.091B | 13.63 |
Insulet (PODD) | United States | $16.158B | 67.98 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.705B | 0.00 |
Demant (WILYY) | Denmark | $9.197B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.972B | 29.73 |
BellRing Brands (BRBR) | United States | $7.584B | 32.07 |
Lantheus Holdings (LNTH) | United States | $7.223B | 17.34 |
ICU Medical (ICUI) | United States | $4.254B | 40.60 |
Haemonetics (HAE) | United States | $3.749B | 18.55 |
Perrigo (PRGO) | Ireland | $3.702B | 11.70 |
Prestige Consumer Healthcare (PBH) | United States | $3.613B | 18.00 |
TG Therapeutics (TGTX) | United States | $3.590B | 38.02 |
GN Store Nord (GNNDY) | Denmark | $3.560B | 21.44 |
Neogen (NEOG) | United States | $3.357B | 35.23 |
Envista Holdings (NVST) | United States | $3.210B | 17.13 |
QuidelOrtho (QDEL) | United States | $3.012B | 18.98 |
Agios Pharmaceuticals (AGIO) | United States | $2.556B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.190B | 36.75 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.172B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.981B | 52.80 |
AdaptHealth (AHCO) | United States | $1.451B | 10.48 |
Warby Parker (WRBY) | United States | $1.445B | 0.00 |
InMode (INMD) | Israel | $1.407B | 8.96 |
AtriCure (ATRC) | United States | $1.349B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.124B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.120B | 0.00 |
Owens & Minor (OMI) | United States | $1.109B | 8.57 |
Evolus (EOLS) | United States | $1.039B | 0.00 |
PetIQ (PETQ) | United States | $0.916B | 23.23 |
Phibro Animal Health (PAHC) | United States | $0.859B | 17.82 |
National Vision Holdings (EYE) | United States | $0.816B | 25.95 |
Cresco Labs (CRLBF) | United States | $0.810B | 0.00 |
Surmodics (SRDX) | United States | $0.557B | 118.21 |
Valneva SE (VALN) | France | $0.486B | 0.00 |
Quanterix (QTRX) | United States | $0.479B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.470B | 14.17 |
ZimVie (ZIMV) | United States | $0.448B | 41.64 |
Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
Jin Medical (ZJYL) | China | $0.394B | 0.00 |
Cerus (CERS) | United States | $0.378B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.341B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.318B | 8.19 |
Biote (BTMD) | United States | $0.311B | 14.32 |
Aurora Cannabis (ACB) | Canada | $0.309B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.303B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.290B | 31.12 |
Zynex (ZYXI) | United States | $0.250B | 43.83 |
Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.229B | 15.22 |
MacroGenics (MGNX) | United States | $0.226B | 0.00 |
Omeros (OMER) | United States | $0.217B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.177B | 0.00 |
FitLife Brands (FTLF) | United States | $0.155B | 20.87 |
TriSalus Life Sciences (TLSI) | United States | $0.151B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.136B | 0.00 |
Brainsway (BWAY) | Israel | $0.134B | 161.00 |
Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
Veru (VERU) | United States | $0.122B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.120B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
Fonar (FONR) | United States | $0.105B | 10.61 |
Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 23.60 |
InterCure (INCR) | Israel | $0.090B | 15.15 |
Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
Safety Shot (SHOT) | United States | $0.072B | 0.00 |
Modular Medical (MODD) | United States | $0.071B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
Exagen (XGN) | United States | $0.052B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.050B | 3.25 |
Apyx Medical (APYX) | United States | $0.043B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
Bright Green (BGXX) | United States | $0.039B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.020B | 0.00 |
GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Flora Growth (FLGC) | United States | $0.012B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
Sharps Technology (STSS) | United States | $0.007B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 20.07 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |